103 related articles for article (PubMed ID: 32089541)
21. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
22. E6/E7 and E6
Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
Front Immunol; 2019; 10():1676. PubMed ID: 31396215
[TBL] [Abstract][Full Text] [Related]
23. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
[TBL] [Abstract][Full Text] [Related]
24. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
Reuschenbach M; Waterboer T; Wallin KL; Einenkel J; Dillner J; Hamsikova E; Eschenbach D; Zimmer H; Heilig B; Kopitz J; Pawlita M; Doeberitz Mv; Wentzensen N
Int J Cancer; 2008 Dec; 123(11):2626-31. PubMed ID: 18785210
[TBL] [Abstract][Full Text] [Related]
25. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
[TBL] [Abstract][Full Text] [Related]
26. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
[TBL] [Abstract][Full Text] [Related]
27. HPV16 E6 29-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function.
Thomas KJ; Smith KL; Youde SJ; Evans M; Fiander AN; Borysiewicz LK; Man S
Int J Cancer; 2008 Jun; 122(12):2791-9. PubMed ID: 18366058
[TBL] [Abstract][Full Text] [Related]
28. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.
Silins I; Avall-Lundqvist E; Tadesse A; Jansen KU; Stendahl U; Lenner P; Zumbach K; Pawlita M; Dillner J; Frankendal B
Gynecol Oncol; 2002 May; 85(2):333-8. PubMed ID: 11972397
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
31. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
32. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
Subbaramaiah K; Dannenberg AJ
Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
[TBL] [Abstract][Full Text] [Related]
34. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer.
Ellis JR; Keating PJ; Baird J; Hounsell EF; Renouf DV; Rowe M; Hopkins D; Duggan-Keen MF; Bartholomew JS; Young LS
Nat Med; 1995 May; 1(5):464-70. PubMed ID: 7585096
[TBL] [Abstract][Full Text] [Related]
35. Subcellular localization and quantitation of the human papillomavirus type 16 E6 oncoprotein through immunocytochemistry detection.
Jackson R; Togtema M; Zehbe I
Virology; 2013 Jan; 435(2):425-32. PubMed ID: 23084288
[TBL] [Abstract][Full Text] [Related]
36. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
[TBL] [Abstract][Full Text] [Related]
37. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
38. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas.
Kreimer AR; Clifford GM; Snijders PJ; Castellsagué X; Meijer CJ; Pawlita M; Viscidi R; Herrero R; Franceschi S;
Int J Cancer; 2005 Jun; 115(2):329-32. PubMed ID: 15688391
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.
Lehtinen M; Pawlita M; Zumbach K; Lie K; Hakama M; Jellum E; Koskela P; Luostarinen T; Paavonen J; Pukkala E; Sigstad E; Thoresen S; Dillner J
Am J Obstet Gynecol; 2003 Jan; 188(1):49-55. PubMed ID: 12548195
[TBL] [Abstract][Full Text] [Related]
40. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
